And I dont understand why you cant see the same history of Aderan and Intercontex may happen to Shiseido if RCH-01 could not offer much regrowth. People only notice hair loss once they lose more than 50% of their hair and this is why regrowth is the reason for commercialization. Replicel phase 1 gave 10%-17% regrowth after 6 months and Shiseido's job is to maximize this number (and obviously, 5% after 6months reported by @Long John Silver is just a shame and shock, I still hope it was a troll or he misheard the info) and if they couldnt, I doubt they will bring it to the market.
I dont expect RCH regrowth and full head of hair BUT, maintenance + says, 20% regrowth, is ideal for business, at least, they have to beat the current treatment, i.e. finasteride / dutasteride / min.
I hope as much as you that RCH will be available asap.
Last edited:
